Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism

Journal of Medical Virology

Volumn 58, Issue 3, 1999, Pages 256-263

  Candotti, Daniel ^a   Costagliola, Dominique ^b   Joberty, Cathy ^a   Bonduelle, Olivia ^a   Rouzioux, Christine ^c   Autran, Brigitte ^a   Agut, Henri ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Heterogeneity; Long term non progressor; Progression; Replication properties; Viral load

Indexed keywords

VIRUS DNA; VIRUS RNA;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NONHUMAN; VIREMIA; VIRUS CHARACTERIZATION; VIRUS DETECTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TITRATION;

CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DISEASE PROGRESSION; DNA, VIRAL; FOLLOW-UP STUDIES; HELA CELLS; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; LYMPHOCYTE COUNT; MACROPHAGES; RNA, VIRAL; TIME FACTORS; VIRAL LOAD; VIRUS REPLICATION;

EID: 0033056221     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199907)58:3<256::AID-JMV11>3.0.CO;2-Z     Document Type: Article

References (39)

1. Amara A, Le Gall S, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolino M, Virelizier J-L, Arenzana-Seisdedos F. 1997. HIV coreceptor downregulation as antiviral principle: SDF-1-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 186:139-146.
2. Barin F, Lahbabi Y, Buzelay L, Lejeune B, Baillou-Beaufils A, Denis F, Mathiot C, M'Boup S, Vithayasai V, Dietrich U, Goudeau A. 1996. Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping. AIDS Res Hum Retroviruses 12:1279-1289.
3. + cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci USA 92:11135-11139.
4. Barré-Sinoussi F, Chermann J-C, Key F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868-871.
5. Björndal A, Deng H, Jansson M, Fiore JR, Colognesi C, Karlsson A, Albert J, Scarlatti G, Littman DR, Fenyö EM. 1997. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 71:7478-7487.
6. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD. 1994. Long-term HIV-1 infection without immunologic progression. AIDS 8:1123-1128.
7. Candotti D, Jung M, Kerouedan D, Rosenheim M, Gentilini M, M'Pele P, Huraux J-M, Agut H. 1991. Genetic variability affects the detection of HIV by polymerase chain reaction. AIDS 5:1003-1007.
8. Cao YL, Qin L, Zhang L, Safrit J, Ho DD. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 332:201-208.
9. Clerici M, Balotta C, Meroni L, Ferrario E, Riva C, Trabattoni D, Ridolfo A, Villa M, Shearer GM, Moroni M, Galli M. 1996. Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection. AIDS Res Hum Retroviruses 12:1053-1061.
10. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson JS, Cunningham A, Dwyer D, Dowton D, Mills J. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991.
11. + cells is mediated by the chemokine receptor CC-CRK-5. Nature 381:667-673.
12. D'Souza MP, Harden VA. 1996. Chemokines and HIV-1 second receptors. Nat Med 2:1293-1300.
13. Easterbrook PJ. 1994. Non-progression in HIV infection. AIDS 8: 1179-1182.
14. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. 1986. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215-219.
15. Gurgo C, Guo H-G, Franchini G, Aldovini A, CollLTNPi E, Farrell K, Wong-Staal F, Gallo RC, Reitz MS Jr. 1988. Envelope sequences of two new United States HIV-1 isolates. Virology 164:531-536.
16. Hogervorst E, Juriaans S, de Wolf F, van Wijk A, Wiersma A, Valk M, Roos M, van Gemen B, Coutinho R, Miedema F, Goudsmit J. 1995. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J Infect Dis 171:811-821.
17. Iversen AKN, Shpaer EG, Rodrigo AG, Hirsch MS, Walker BD, Sheppard HW, Merigan TC, Mullins JI. 1995. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J Virol 69:5743-5753.
18. Kirschhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. 1995. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332:228-232.
19. Learmont J, Tindall B, Evans L, Cunningham P, Wells J, Penny R, Kaldor J, Cooper DA. 1992. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 340:863-867.
20. Mabondzo A, Le Naour R, Raoul H, Clayette P, Lafuma C, Barré-Sinoussi FC, Cayre Y, Dormont D. 1991. In vitro infection of macrophages by HIV: correlation with cellular activation, synthesis of tumour necrosis factor alpha and proteolytic activity. Res Virol 142:205-212.
21. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
22. Montefiori DC, Pantaleo G, Fink LM, Zhou JT, Zhou JY, Bilska M, Miralles GD, Fauci AS. 1996. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J Infect Dis 173:60-67.
23. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier J-L, Arenzana-Seisdedos F, Schwartz O, Heard J-M, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833-835.
24. Pantaleo G, Graziosi C, Fauci AS. 1993. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328:327-335.
25. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen J, Demarest JF, Montefiori D, Orenstein JM, Fox C, Schrager LK, Margolick JB, Buchbinder S, Giorgi J, Fauci AS. 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332:209-216.
26. Raboud JM, Haley L, Montaner JSG, Murphy C, Januszewska M, Schechter MT. 1995. Sources of variation in CD4 lymphocyte counts. J Acquir Immune Defic Syndr Hum Retrovirol 10 (Suppl 2): S67-S73.
27. Rinaldo CR, Huang X-L, Fan Z, Ding M, Beltz L, Logar A, Panicali D, Mazzara G, Liebmann J, Cottrill M, Gupta P. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol 69:5838-5842.
28. Rouzioux C, Puel J, Agut H, Brun-Vezinet F, Ferchal F, Tamalet C, Descamps P, Fleury H. 1992. Comparative assessment of quantitative HIV viraemia assays. AIDS 6:373-377.
29. Rump J-A, Peter H-H, Schneider J, Haller O, Meyerhans A. 1996. Long-term survivors with continuously high levels of HIV type 1. AIDS Res Hum Retroviruses 12:757-758.
30. Salhi Y, Costagliola D. 1997. Long-term nonprogression in HIV infection [letter]. J Infect Dis 16:409-411.
31. Schrager LK, Young JM, Fowler MG, Mathieson BJ, Vermund SH. 1994. Long-term survivors of HIV-1 infection: definition and research challenges. AIDS 8(Suppl 1):S95-S108.
32. Schuitemarker H, Koot M, Kootstra NA, Dercksen MW, De Goede REY, Van Steewijk RP, Lange JM, Eeftink Schattenkerk JK, Miedema F, Tersmette M. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 66:1354-1360.
33. Schwartz O, Hénin Y, Maréchal V, Montagnier L. 1988. A rapid and simple colorimetric test for the study of anti-HIV agents. AIDS Res Hum Retroviruses 4:441-448.
34. + T-cell levels. AIDS 7:1159-1166.
35. Soriano V, Martin R, del Romero J, Heredia A, Dietrich U, Mas A, Adrados M, Martinez P, Hewlett I, Gonzalez-Lahoz J. 1997. Outcome in a cohort of long-term non-progressors in Madrid: virological and immunological findings. AIDS 11:123-124.
36. Strathdee SA, Veugelers PJ, Page-Shafer KA, McNulty A, Moss AR, Schechter MT, van Griensven GJP, Countinho RA. 1996. Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters. AIDS 10:959-965.
37. Tamalet C, Lafeuillade A, Yahi H, Vignoli C, Tourres C, Pellegrino P, de Micco P. 1994. Comparison of viral burden and phenotype of HIV-1 isolates from lymph nodes and blood. AIDS 8:1083-1088.
38. Vesanen M, Stevens CE, Taylor PE, Rubinstein P, Saksela K. 1996. Stability in controlling viral replication identifies long-term non-progressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons. J Virol 70:9035-9040.
39. Zinkernagel RM, Hengartner H. 1994. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol today 15:262-268.